{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:30Z","timestamp":1786120230540,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5,1]]},"DOI":"10.1097\/qai.0b013e318246538f","type":"journal-article","created":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T04:22:09Z","timestamp":1326342129000},"page":"e1-e7","source":"Crossref","is-referenced-by-count":33,"title":["Cost-Effectiveness of Tuberculosis Diagnostic Strategies to Reduce Early Mortality Among Persons With Advanced HIV Infection Initiating Antiretroviral Therapy"],"prefix":"10.1097","volume":"60","author":[{"given":"Taiwo O.","family":"Abimbola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Marston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand A.","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Blandford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalinee","family":"Sangrujee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan Z.","family":"Wiktor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-16-20210131","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/COH.0b013e328333ad61","article-title":"Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities.","volume":"5","author":"Nachega","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"R4-16-20210131","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","article-title":". Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.","volume":"22","author":"Lawn","year":"2008","journal-title":"AIDS"},{"key":"R5-16-20210131","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/COH.0b013e328333850f","article-title":"Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings.","volume":"5","author":"Lawn","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"R6-16-20210131","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":". Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.","volume":"21","author":"Moore","year":"2007","journal-title":"AIDS"},{"key":"R7-16-20210131","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":". Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.","volume":"20","author":"Lawn","year":"2006","journal-title":"AIDS"},{"key":"R9-16-20210131","doi-asserted-by":"crossref","first-page":"e1000391","DOI":"10.1371\/journal.pmed.1000391","article-title":". Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies.","volume":"8","author":"Getahun","year":"2011","journal-title":"PLoS Med"},{"key":"R10-16-20210131","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1473-3099(09)70043-X","article-title":"Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings.","volume":"9","author":"Reid","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R12-16-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11030","article-title":". A systematic review of rapid diagnostic tests for the detection of tuberculosis infection.","volume":"11","author":"Dinnes","year":"2007","journal-title":"Health Technol Assess"},{"key":"R15-16-20210131","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":". Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.","volume":"367","author":"Braitstein","year":"2006","journal-title":"Lancet"},{"key":"R19-16-20210131","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/027298902400448867","article-title":". Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease.","volume":"22","author":"Briggs","year":"2002","journal-title":"Med Decis Making"},{"key":"R20-16-20210131","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hec.635","article-title":"Representing uncertainty: the role of cost-effectiveness acceptability curves.","volume":"10","author":"Fenwick","year":"2001","journal-title":"Health Econ"},{"key":"R21-16-20210131","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0905848","article-title":". Timing of initiation of antiretroviral drugs during tuberculosis therapy.","volume":"362","author":"Abdool Karim","year":"2010","journal-title":"N Engl J Med"},{"key":"R22-16-20210131","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1086\/656282","article-title":". Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa.","volume":"51","author":"Bassett","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R23-16-20210131","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":". Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTBRIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.","volume":"377","author":"Boehme","year":"2011","journal-title":"Lancet"},{"key":"R24-16-20210131","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa0907488","article-title":". An algorithm for tuberculosis screening and diagnosis in people with HIV.","volume":"362","author":"Cain","year":"2010","journal-title":"N Engl J Med"},{"key":"R25-16-20210131","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00002030-200404090-00006","article-title":". Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa.","volume":"18","author":"Coetzee","year":"2004","journal-title":"AIDS"},{"key":"R26-16-20210131","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/JCM.42.5.2321-2325.2004","article-title":". Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria.","volume":"42","author":"Cruciani","year":"2004","journal-title":"J Clin Microbiol"},{"key":"R27-16-20210131","first-page":"523","article-title":". Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa.","volume":"10","author":"Day","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"R28-16-20210131","first-page":"1021","article-title":"Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.","volume":"12","author":"Dowdy","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"R29-16-20210131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2334-10-23","article-title":". The tuberculosis challenge in a rural South African HIV programme.","volume":"10","author":"Houlihan","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R30-16-20210131","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1086\/597098","article-title":". High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy.","volume":"48","author":"Koenig","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R31-16-20210131","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1097\/QAD.0b013e32832e05c8","article-title":". Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"R32-16-20210131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00002030-200101260-00002","article-title":"Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa.","volume":"15","author":"Mukadi","year":"2001","journal-title":"AIDS"},{"key":"R33-16-20210131","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/QAI.0b013e318196761c","article-title":". Intensified tuberculosis case finding among HIV-infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia.","volume":"50","author":"Shah","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R34-16-20210131","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.qai.0000159668.80207.5b","article-title":". Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.","volume":"40","author":"Wester","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R35-16-20210131","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/QAD.0b013e328325d115","article-title":". Effect of pulmonary tuberculosis on mortality in patients receiving HAART.","volume":"23","author":"Westreich","year":"2009","journal-title":"AIDS"},{"key":"R36-16-20210131","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1164\/rccm.200905-0692OC","article-title":". Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus.","volume":"180","author":"Monkongdee","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R37-16-20210131","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","article-title":". Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.","volume":"365","author":"Blanc","year":"2011","journal-title":"N Engl J Med"},{"key":"R38-16-20210131","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","article-title":". Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.","volume":"365","author":"Havlir","year":"2011","journal-title":"N Engl J Med"},{"key":"R40-16-20210131","first-page":"1024","article-title":". Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting.","volume":"14","author":"Chihota","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"R41-16-20210131","doi-asserted-by":"crossref","first-page":"11293","DOI":"10.1073\/pnas.0800965105","article-title":". Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing.","volume":"105","author":"Dowdy","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R45-16-20210131","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1478-7547-4-20","article-title":"The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africaa primary data analysis.","volume":"4","author":"Cleary","year":"2006","journal-title":"Cost Eff Resour Alloc"},{"key":"R46-16-20210131","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1365-3156.2008.02114.x","article-title":"The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa.","volume":"13","author":"Rosen","year":"2008","journal-title":"Trop Med Int Health"},{"key":"R47-16-20210131","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2471\/BLT.07.044248","article-title":". Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.","volume":"86","author":"Brinkhof","year":"2008","journal-title":"Bull World Health Organ"},{"key":"R49-16-20210131","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/QAD.0b013e3283390dd1","article-title":". Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.","volume":"24","author":"Lawn","year":"2010","journal-title":"AIDS"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201205010-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:29:52Z","timestamp":1786048192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201205010-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318246538f","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,1]]}}}